Epidermal growth factor-mediated targeting of chlorin e6 selectively potentiates its photodynamic activity

Cancer Research

Volumn 60, Issue 8, 2000, Pages 2197-2202

  Gijsens, Antoon ^a   Missiaen, Ludwig ^a   Merlevede, Wilfried ^a   De Witte, Peter ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Campus Gasthuisberg O+N   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; TALAPORFIN;

ARTICLE; BREAST CARCINOMA; CYTOTOXICITY; HUMAN; HUMAN CELL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECEPTOR DENSITY; TREATMENT OUTCOME;

ADENOCARCINOMA; BINDING, COMPETITIVE; BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; CELL DIVISION; DEXTRANS; DRUG SYNERGISM; EPIDERMAL GROWTH FACTOR; HUMANS; INHIBITORY CONCENTRATION 50; PHOTOCHEMOTHERAPY; PORPHYRINS; RADIATION-SENSITIZING AGENTS; REACTIVE OXYGEN SPECIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; SERUM ALBUMIN; SUBSTRATE SPECIFICITY; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034655147     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Pass, H. I. Photodynamic therapy in oncology: mechanisms and clinical use. J. Natl. Cancer Inst., 85: 443-456, 1993.
2. Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., and Peng, Q. Photodynamic therapy. J. Natl. Cancer Inst., 90: 889-905, 1998.
3. Jori, G. Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy. J. Photochem. Photobiol. B Biol., 36: 87-93, 1996.
4. Manyak, M. J., Russo, A., Smith, P. D., and Glatstein, E. Photodynamic therapy. J. Clin. Oncol., 6: 380-391, 1988.
5. Mew, D., Wat, C. K., Towers, G. H., and Levy, J. G. Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. J. Immunol., 130: 1473-1477, 1983.
6. 6 covalently bound to monoclonal antibodies using a modified dextran carrier. Proc. Natl. Acad. Sci. USA, 87: 4217-4221, 1990.
7. Jiang, F. N., Richter, A. M., Ashok, K. J., Levy, J. G., and Smits, C. Biodistribution of a benzoporphyrin derivative-monoclonal antibody conjugate in A549-tumor-bearing nude mice. Biotechnol. Ther., 4: 43-61, 1993.
8. Hamblin, M. R., and Newman, E. L. Photosensitizer targeting in photodynamic therapy. II. Conjugates of haematoporphyrin with serum lipoproteins. J. Photochem. Photobiol. B Biol., 26: 147-157, 1994.
9. Schmidt Erfurth, U., Diddens, H., Birngruber, R., and Hasan, T. Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates. Br. J. Cancer. 75: 54-61, 1997.
10. 6. Cancer Res., 55: 1014-1019, 1995.
11. Hamblin, M. R., and Newman, E. L. Photosensitizer targeting in photodynamic therapy. I. Conjugates of haematoporphyrin with albumin and transferrin. J. Photochem. Photobiol. B Biol., 26: 45-56, 1994.
12. Modjtahedi, H., and Dean, C. The receptor for EGF and its ligands: expression, prognostic value and target for therapy in cancer. Int. J. Oncol., 4: 277-296, 1994.
13. Voldborg, B. R., Damstrup, L., Spang Thomsen, M., and Poulsen, H. S. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Ann. Oncol., 8: 1197-1206, 1997.
14. 131I conjugates on the clonogenic survival of cultured glioma cells. J. Neurooncol., 14: 213-223, 1992.
15. Capala, J., Barth, R. F., Bendayan, M., Lauzon, M., Adams, D. M., Soloway, A. H., Fenstermaker, R. A., and Carlsson, J. Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors. Bioconjug. Chem., 7: 7-15, 1996.
16. Lee, C. H., Lee, E. C., Tsai, S. T., Kung, H. J., Liu, Y. C. and Hwang, J. An EGF-Pseudomonas exotoxin A recombinant protein with a deletion in toxin binding domain specifically kills EGF receptor bearing cells. Protein Eng., 6: 433-440, 1993.
17. Shaw, J. P., Akiyoshi, D. E., Arrigo, D. A., Rhoad, A. E., Sullivan, B., Thomas, J., Genbauffe, F. S., Bacha, P., and Nichols, J. C. Cytotoxic properties of DAB486EGF and DAB389EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins. J. Biol. Chem., 266: 21118-21124, 1991.
18. Haigler, H., Ash, J. F., Singer, S. J., and Cohen, S. Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431. Proc. Natl. Acad. Sci. USA, 75: 3317-3321, 1978.
19. Haigler, H. T., McKanna, J. A., and Cohen, S. Direct visualization of the binding and internalization of a ferritin conjugate of epidermal growth factor in human carcinoma cells A-431. J. Cell Biol., 81: 382-395, 1979.
20. Linsley, P. S., and Fox, C. F. Direct linkage of EGF to its receptor: characterization and biological relevance. J. Supramol. Struct., 14: 441-459, 1980.
21. Hollenberg, M. D., and Gregory, H. Human urogastrone and mouse epidermal growth factor share a common receptor site in cultured human fibroblasts. Life Sci., 20: 267-274, 1977.
22. Struthers, J. E., and Newman, E. L. A conjugate between haematoporphyrin and EGF as a potential tumour-targeted photosensitizer. In: Third Biennial Meeting of the International Photodynamic Association, p. 33. Buffalo, NY, 1990.
23. 6 ethylenediamide in vitro and in vivo. J. Photochem. Photobiol. B Biol., 13: 51-57, 1992.
24. 6 conjugates. Photochem. Photobiol., 65: 723-729, 1997.
25. Filmus, J., Pollak, M. N., Cailleau, R., and Buick, R. N. MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem. Biophys. Res. Commun., 128: 898-905, 1985.
26. Savage, C. R., and Cohen, S. Epidermal growth factor and a new derivative. J. Biol. Chem., 247: 7609-7611, 1972.
27. 6 antibacterial immunoconjugates. J. Immunol. Methods, 156: 85-99, 1992.
28. Andersson, A., Holmberg, A., Carlsson, J., Pontén, J., and Westermark, B. Binding of epidermal growth factor-dextran conjugates to cultured glioma cells. Int. J. Cancer. 47: 439-444, 1991.
29. 6 internalizable conjugates on A431 cells. Int. J. Oncol., 13: 1171-1177, 1998.
30. Rousseau, D. L., Staros, J. V., and Beechem, J. M. The interaction of epidermal growth factor with its receptor in A431 cell membranes: a stopped-flow fluorescence anisotropy study. Biochemistry, 34: 14508-14518, 1995.
31. Palombella, V. J., and Vilcek, J. Mitogenic and cytotoxic actions of tumor necrosis factor in BALB/c 3T3 cells. J. Biol. Chem., 264: 18128-18136, 1989.
32. Lin, C. W., Shulok, J. R., Wong, Y. K., Schanbacher, C. F., Cincotta, L., and Foley, J. W. Photosensitization, uptake and retention of phenoxazine Nile blue derivatives in human bladder carcinoma cells. Cancer Res., 51: 1109-1116, 1991.
33. Lee, Y. J., Galaforo, S. S., Berns, C. M., Chen, J. C., Davis, B. H., Sim, J. E., Corry, P. M., and Spitz, D. R. Glucose deprivation-induced cytotoxicity and alterations in mitogen-activated protein kinase activation are mediated by oxidative stress in multidrug-resistant human breast carcinoma cells. J. Biol. Chem., 273: 5294-5299, 1998.
34. Bermbach, U., and Faulstich, H. Epidermal growth factor labeled β-amanitin-poly-L-ornithine: preparation and evidence for specific cytotoxicity. Biochemistry, 29: 6839-6845, 1990.
35. Olsson, P., Lindström, A., and Carlsson, J. Internalization and excretion of epidermal growth factor-dextran-associated radioactivity in cultured squamous-carcinoma cells. Int. J. Cancer, 56: 529-537, 1994.
36. Koffman, C. G., Elder, J. B., Ganguli, P. C., Gregory, H., and Geary, C. G. Effect of urogastrone on gastric secretion and serum gastrin concentration in patients with duodenal ulceration. Gut, 23: 951-956, 1982.
37. Duncan, R., and Spreafico, F. Polymer conjugates. Clin. Pharmacokinet., 27: 290-306, 1994.
38. Bitonti, A. J., Dumont, J. A., Bush, T. L., Cashman, E. A., Cross-Doersen, D. E., Wright, P. S., Matthews, D. P., McCarthy, J. R., and Kaplan, D. A. Regression of human breast tumor xenografts in response to (E)-2′-deoxy-2′-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase. Cancer Res., 54: 1485-1490, 1994.
39. McCloskey, D. E., Kaufmann, S. H., Prestigiacomo, L. J., and Davidson, N. E. Paclitaxel induces programmed cell death in MDA-MB-468 human breast cancer cells. Clin. Cancer Res., 2: 847-854, 1996.
40. Schlessinger, J. The epidermal growth factor receptor as a multifunctional allosteric protein. Biochemistry, 27: 3119-3123, 1988.
41. Kohn, J., and Wilchek, M. The use of cyanogen bromide and other novel cyanylating agents for the activation of polysaccharide resins. Appl. Biochem. Biotechnol., 9: 285-305, 1984.
42. Lindström, A. Targeting to EGF Receptors. In: Preparation of EGF-Dextran Conjugates and Analysis of Their Metabolism in Vitro and in Vivo, pp. 14-15. Uppsala, Sweden: Acta Universitatis Upsaliensis Nova Acta Regiae Societatis Scientiarum Upsaliensis, 1993.
43. Wong, S. S. Dialdehydes. In: Chemistry of Protein Conjugation and Cross-Linking, pp. 101-103. Boca Raton, FL: CRC Press, 1993.